BURCON NUTRASCIENCE CORP (BU.CA) Stock Price & Overview

TSX:BU • CA1208313009

2.41 CAD
-0.09 (-3.6%)
Last: Mar 5, 2026, 07:00 PM

The current stock price of BU.CA is 2.41 CAD. Today BU.CA is down by -3.6%. In the past month the price increased by 26.84%. In the past year, price increased by 33.89%.

BU.CA Key Statistics

52-Week Range1.51 - 5
Current BU.CA stock price positioned within its 52-week range.
1-Month Range1.8 - 2.5
Current BU.CA stock price positioned within its 1-month range.
Market Cap
30.583M
P/E
N/A
Fwd P/E
0.37
EPS (TTM)
-1.06
Dividend Yield
N/A

BU.CA Stock Performance

Today
-3.6%
1 Week
+11.57%
1 Month
+26.84%
3 Months
+43.45%
Longer-term
6 Months +4.78%
1 Year +33.89%
2 Years -59.15%
3 Years -55.37%
5 Years -97.43%
10 Years -96.40%

BU.CA Stock Chart

BURCON NUTRASCIENCE CORP / BU Daily stock chart

BU.CA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to BU.CA. When comparing the yearly performance of all stocks, BU.CA is one of the better performing stocks in the market, outperforming 73.28% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
BU.CA Full Technical Analysis Report

BU.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BU.CA. BU.CA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BU.CA Full Fundamental Analysis Report

BU.CA Earnings

On February 11, 2026 BU.CA reported an EPS of -0.28 and a revenue of 739.10K. The company missed EPS expectations (-579.61% surprise) and missed revenue expectations (-28.24% surprise).

Next Earnings DateJun 22, 2026
Last Earnings DateFeb 11, 2026
PeriodQ3 / 2026
EPS Reported-CA$0.28
Revenue Reported739.1K
EPS Surprise -579.61%
Revenue Surprise -28.24%
BU.CA Earnings History

BU.CA Forecast & Estimates

For the next year, analysts expect an EPS growth of -803.01% and a revenue growth 146.15% for BU.CA


Analysts
Analysts84.44
Price TargetN/A
EPS Next Y-803.01%
Revenue Next Year146.15%
BU.CA Forecast & Estimates

BU.CA Groups

Sector & Classification

BU.CA Financial Highlights

Over the last trailing twelve months BU.CA reported a non-GAAP Earnings per Share(EPS) of -1.06. The EPS decreased by -89.9% compared to the year before.


Income Statements
Revenue(TTM)1.48M
Net Income(TTM)-12.90M
Industry RankSector Rank
PM (TTM) N/A
ROA -53.81%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-40%
Sales Q2Q%1131.83%
EPS 1Y (TTM)-89.9%
Revenue 1Y (TTM)337.48%
BU.CA financials

BU.CA Ownership

Ownership
Inst Owners5.83%
Shares12.69M
Float8.76M
Ins Owners31.02%
Short Float %N/A
Short RatioN/A
BU.CA Ownership

About BU.CA

Company Profile

BU logo image Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries. The company is headquartered in Vancouver, British Columbia and currently employs 15 full-time employees. The firm has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The company is engaged in the production of hemp protein isolate and the provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. The company extracts and purifies a canola protein isolate from canola meal. The company has branded this protein isolate under the trade name Puratein C. It provides consulting and contract services, product and process development, and process scale-up and validation. The company also operates a protein production facility located in Galesburg, Illinois.

Company Info

BURCON NUTRASCIENCE CORP

490-999 West Broadway

Vancouver BRITISH COLUMBIA V6J 1Z2 CA

CEO: Johann F. Tergesen

Employees: 15

BU Company Website

BU Investor Relations

Phone: 16047330896

BURCON NUTRASCIENCE CORP / BU.CA FAQ

What does BU do?

Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries. The company is headquartered in Vancouver, British Columbia and currently employs 15 full-time employees. The firm has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The company is engaged in the production of hemp protein isolate and the provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. The company extracts and purifies a canola protein isolate from canola meal. The company has branded this protein isolate under the trade name Puratein C. It provides consulting and contract services, product and process development, and process scale-up and validation. The company also operates a protein production facility located in Galesburg, Illinois.


What is the current price of BU stock?

The current stock price of BU.CA is 2.41 CAD. The price decreased by -3.6% in the last trading session.


Does BU stock pay dividends?

BU.CA does not pay a dividend.


What is the ChartMill technical and fundamental rating of BU stock?

BU.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


On which exchange is BU.CA stock listed?

BU.CA stock is listed on the Toronto Stock Exchange exchange.


What is the Price/Earnings (PE) ratio of BURCON NUTRASCIENCE CORP (BU.CA)?

BURCON NUTRASCIENCE CORP (BU.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.06).


What is BURCON NUTRASCIENCE CORP worth?

BURCON NUTRASCIENCE CORP (BU.CA) has a market capitalization of 30.58M CAD. This makes BU.CA a Nano Cap stock.